• Sorry! To unlock all site features, we'll need to collect some information from you.
  • Unit 7.4: Direct Antithrombins

    George D. Dangas, MD, PhD — Columbia University Medical Center, Cardiovascular Research Foundation

    Duration:1 hour

    Faculty Disclosure

    Nothing to Disclose

    Learning Objectives

    • Mechanism of action, differences from heparin
    • Comparison between agents, safety and efficacy considerations
    • Clinical results from use of bivalirudin in PCI and ACS
    • Future directions